Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neoadjuvant therapy with trastuzumab, paclitaxel and epirubicin for HER-2-positive operable breast cancer.

× No keyword cloud information.

3 in total

Review 1. Incorporation of biomarkers in phase II studies of recurrent glioblastoma.

Authors: Toni Rose Jue; Elizabeth Hovey; Sara Davis; Oliver Carleton; Kerrie L McDonald
Journal: Tumour Biol Date: 2014-12-23

2. HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination.

Authors: Daniel G Tiezzi; Jurandyr M Andrade; Alfredo Ribeiro-Silva; Fábio E Zola; Heitor R C Marana; Marcelo G Tiezzi
Journal: BMC Cancer Date: 2007-02-26 Impact factor: 4.430

Review 3. Targeted therapeutic options and future perspectives for HER2-positive breast cancer.

Authors: Jiani Wang; Binghe Xu
Journal: Signal Transduct Target Ther Date: 2019-09-13

3 in total